Table 2

Gene expression studies: dissected aorta ascendens vs. control aorta. Gene expression studies that comparing freshly dissected aorta ascendens (D) and undissected control aorta (C). 3 different gene expression studies were performed: 16 samples were studied with BD Atlas™ Human1.2 Array (h), 16 samples – with BD Atlas™ Human Cardiovascular Array (c) and 8 samples – with Affymetrix Human Genome U133A GeneChip. All differently expressed genes of the Atlas-experiments, 49 genes (h) and 33 genes (c), are shown and compared to genes of the Affymetrix experiment. Ratio: mean expression of dissected aorta (D) divided by mean expression of control (C); n.e.: not expressed, n.s.: difference not significant. n.t.: not tested, ↓ downregulated, ↑ upregulated; ? – regulation in the Atlas and Affymetrix experiment different

Gene Name
Platform
Atlas
Affymetrix
regulation
Functional group
Array type
ratio D/C
P value
ratio D/C
P value


extracellular matrix proteins,






cell surface antigens, adhesion proteins






collagen IV α2, COL4A2
h
0.5
<0.01
0.4
<0.05

collagen IV α5, COL4A5

n.t.

0.32
<0.05

collagen VI α3, COL6A3
c
1.9
<0.05

n.s.
?
collagen VIII α1, COL8A1
c
0.3
<0.01
0.3
<0.001

collagen VIII α2, COL8A2

n.t.

0,4
<0,01

collagen XIV α1, COL14A1, undulin
c
0.4
<0.001
0.5
<0.001

collagen XVIII α1, COL18A1

n.t.

0.47
<0.001

polycystin1, PKD1
h
0.3
<0.001
0.4
<0.01

polycystin 2, PKD2

n.t.

0.4
<0.001

clusterin, SP-40;
h
0.5
<0.01
0.5
<0.01

integrin α7B, IGA7B
h
0.4
<0.001
0.3
<0.001

gap junction protein, connexin 43
c
0.6
<0.05

n.s.
?
SPARC-like 1
c
0.3
<0.001
0.6
<0.001

decorin
c
0.3
<0.05

n.s.

elastin

n.t.

0.4
<0.05

fibulin 5

n.t.

0.4
<0.001

cell surface glycoprotein MUC18
h
0.3
<0.001
0.5
<0.01

fibronectin receptor
h
n.s.

3.4
<0.01

ras homolog gene family member B
h
0.5
<0.05

n.s.
?
extracellular matrix proteolysis






MMP-11
h
2.1
<0.001
3.2
<0.05

MMP-14

n.t.

2.5
<0.01

MMP-19

n.t.

3.2
<0.05

TIMP1
h,c
1.8
<0.01

n.s.
?
TIMP2
h,c
0.4
<0.01

n.s.
?
TIMP3
c
0.2
<0.001

n.s.
?
cell motility and cytoskeleton proteins






vinculin
c
0.2
<0.001

n.s.
?
actinin α1
c
0.5
<0.001
0.8
<0.01

filamin A
c
0.3
<0.001
0.5
<0.001

actin α2

n.t.

0.13
<0.001

actinin α4

n.t.

0.44
<0.001

gelsolin

n.t.

0.5
<0.01

leiomodin

n.t.

0.4
<0.01

tropomyosin 1

n.t.

0.4
<0.01

calponin

n.t.

0.3
<0.001

smooth & non-muscle myosin light chain kinase
h
0.4
<0.001
n.t.


smooth muscle myosin heavy chain, SM2

n.t.

0.5
<0.001

myosin regulatory light chain2, smooth muscle

n.t.

0.5
<0.001

metabolism

n.t.




low-density lipoprotein receptor, LDLR
c
0.4
<0.001
1.6
<0.01
?
Kunitz-type serine protease inhibitor 2, SPINT2
h
0.2
<0.001
0.3
<0.001

aldehyde dehydrogenase 2, mitochondrial
c
0.3
<0.01
0.6
<0.01

diaphorase (NADH), cytochrome b-5 reductase
c
0.5
<0.01

n.s.
?
superoxide dismutase 3, extracellular
c
0.4
<0.01
0.4
<0.001

lipase A
c
2.6
<0.05

n.s.
?
protease inhibit, PI1, alpha-1-antitrypsin
h
5.5
<0.001



GABA-B receptor 1A subunit
h
1.8
<0.001
n.e.

?
prostaglandin I2 prostacyclin synthetase
c
0.4
<0.05
0.81
<0,001


Gene Name
Platform
Atlas
Affymetrix
regulation
Functional group
Array type
ratio D/C
P value
ratio D/C
P value
ratio D/C

Protein turnover






purine-rich element-binding protein A
h
0.4
<0.01
0.6
<0.05

glutathione S-transferase theta 1
h
0.4
<0.01
0.2
<0.05

58-kDa inhibit. of RNA-activated protein kinase
h
0.3
<0.01



G1/S-specific cyclin D1
h
0.5
<0.01

n.s.
-
carboxypeptidase H, CPE; enkephalin convertase
h
0.4
<0.01



ribos. protein S6 kinase II α1, S6KII-alpha 1
h
3.1
<0.001

n.s.
-
carboxypeptidase N, polypeptide 1, 50 kD
c
2.0
<0.05
n.e.

-
eukariotic translation initiantion factor 4E bind prot 1

n.t.

2.9
<0.01

60 S acdic ribosomal protein PO

n.t.

3.0
<0.01

FOS-related antigen 1
h,c
4.9
<0.01
3.6
<0.05

myc proto-oncogene
h
3.5
<0.01
2.8
<0.05

ets domain protein elk-3; NET; SRF accessory protein
h
2.1
<0.001
4.4
<0.05

adenine phosphoribosyltransferase

n.t.

2.1
<0.001

high mobility group prot isoforms I & Y, HMGIY
h
10.1
<0.001
6,0
<0.01

superoxide dismutase 2, mitochondrial
c
2.6
<0.01
3.7
<0.001

Cell receptors






Natriuretic peptide receptor A/guanylate cyclase A
c
0.4
<0.001
0.3
<0.001

natriuretic peptide receptor C/guanylate cyclase C
c
0.5
<0.001

n.s.
-
protein tyrosine phosphatase receptor type F
c,h
0.4
<0.01
n.t.

-
growth factors






vascular endothelial growth factor, VEGF
h
4.7
<0.05

n.s.
-
endothelin 2
c
0.6
<0.01
n.e.

-
fibroblast growth factor receptor1
h
0.6
<0.01
0.7
<0.05

insulin-like growth factor-binding protein 2, IGFBP2
h
0.3
<0.001
0.2
<0.01

cardiotrophin 1
c
0.4
<0.001
0.5
>0.05

pleiotrophin, heparin-binding growth factor 8, HBGF8
h
0.5
<0.05
0.6
<0.05

inflammation + stress response






colony-stimulating factor 1 receptor, CSF1R
h
2.0
<0.05
1.7
<0.05

myeloid cell nuclear differentiation antigen
h
3.5
<0.001
3.9
<0.05

tumor necrosis fact recept superfam memb 1B
h
2.0
<0.001

n.s.
-
granulocyte colony stimul factor recept
h
3.5
<0.01
n.e.

-
interleukin 2 receptor alpha subunit, IL-2, CD25 antigen
h
3.1
<0.001
5.3
<0.001

interleukin 6, IL-6
h
3.9
<0.01
4.3
<0.001

interleukin 8, IL-8



12.2
<0.05

small inducible cytokine subfamily A member 2
h,c
3.8
<0.01
2.2
<0.05

90-kDa heat-shock proteinA HSP90A
h
2.6
<0.05
n.t.


60-kDa heat shock protein HSP60
h
2.7
<0.05
n.t.


CD9 antigen p24
c
0.5
<0.001
0.5
<0.01

27-kDa heat shock protein HSP27
h
0.4
<0.001
n.t.

-
blood, hemostasis






endothelial plasminogen activator inhibit 1, PAI1
h
2.8
<0.05
4.0
<0.05

thrombomodulin
h
2.8
<0.05

n.s.
-
hexabrachion, tenascin C
c
2.6
<0.01
6.2
<0.05

heme oxygenase 1
h
15.4
<0.05
3.6
<0.05

tissue factor pathway inhibit, coagulation inhibit
c
2.0
<0.05
1.6
<0.05

tissue factor pathway inhibitor 2
c
2.3
<0.05
3.0
<0.05

others






c-fgr proto-oncogene p55-FGR
h
2.6
<0.01
2.6
<0.01

erbB3 proto-oncogene; HER3
h
3.7
<0.001
n.t.


caspase 4
h
1.9
<0.05
n.t.


follistatin-related protein
h
0.5
<0.01
0.6
<0.01

Gem; induced immediate early protein
h
0.2
<0.001
0.3
<0.001

parathymosin athymosin
h
0.6
<0.05
0.8
n.s.
-
prostaglandin I2 (prostacyclin) synthase
c
0.4
<0.05
n.t.
<0.001

calcium-activated potassium channel beta subunit
h
0.3
<0.001
0.4
<0.01

solute carrier fam 4 anion exchanger member 3
c
0.5
<0.001
n.t.

-

Weis-Müller et al. Journal of Translational Medicine 2006 4:29   doi:10.1186/1479-5876-4-29